The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday backed the Food and Drug Administration’s (FDA) decision to offer COVID-19 booster doses after five months, rather than six months.
STOCKHOLM—Sweden’s Public Health Agency said on Monday it recommended the use of Pfizer-BioNTech’s, Comirnaty vaccine against COVID-19 for children between 12-15, opting against rival Moderna’s Spikevax. The European Medicines Agency approved the use of Comirnaty in May, while Spikevax was given the nod for children over 12 in July. “All in all, we see a […]
President Joe Biden received his COVID-19 vaccine booster shot on camera in the White House Monday just days after a third dose was recommended for certain groups by a CDC advisory committee. Third doses of the Pfizer-BioNTech vaccine have been approved by the FDA and CDC for people over the age of 65, people over […]
While Pfizer and Moderna are pushing for COVID-19 vaccine booster shots, staff at the Food and Drug Administration (FDA) are yet to take a stance, citing a lack of verified data. In a 23-page document (pdf) published to the agency’s website on Wednesday, FDA staff noted that the expected benefits of booster vaccinations depend entirely on the impact they have […]
An advisory group of the Centers for Disease Control and Prevention (CDC) unanimously endorsed the full approval of the Pfizer–BioNTech COVID-19 Vaccine for U.S. citizens who are over the age of 16. The Advisory on Immunization Practices (ACIP), a committee within the CDC, said on Monday that the vaccine by Pfizer–BioNTech against the CCP (Chinese […]
The Food and Drug Administration approves the Pfizer vaccine as President Joe Biden calls for new vaccine mandates, the pressure is on to evacuate the tens of thousands of people waiting to leave Afghanistan, and the death toll from the flash floods in Tennessee is rising.
Moderna and the Pfizer-BioNTech alliance could reap billions from COVID-19 booster shots in the coming years, in what analysts and investors say could be a market comparable to the $6 billion in annual sales for flu vaccines. Pfizer, its German partner BioNTech, and Moderna have together locked in over $60 billion in sales of their […]
